EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

NRF2 Dysregulation and Therapeutic Insights Across Chronic Kidney Diseases

Tina Si Ting Lim iD, Kar Hui Ng, Yaochun Zhang iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26157471 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Tina Si Ting Lim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117549, Singapore. Hauptthemen laut MEDLINE: NF-E2-Related Factor 2, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 245 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Medical Research Council, Singapore (NMRC).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chronic kidney disease (CKD) remains a global health burden, with limited therapeutic options that effectively target the underlying pathophysiology. Nuclear factor erythroid 2-related factor 2 (NRF2), a key regulator of oxidative stress and inflammation, has garnered significant attention as a potential therapeutic target in CKD. Despite encouraging preclinical results, no NRF2-targeted agents have achieved clinical approval for CKD treatment. This review synthesizes emerging evidence showing substantial heterogeneity in NRF2 activity across CKD subtypes, influenced by disease etiology, CKD stage, and rate of disease progression. We elucidate the key therapeutic implications across diverse CKD etiologies and highlight that the therapeutic efficacy of NRF2 activation depends on precise modulation tailored to disease context. Although NRF2 overactivation and the need for stage-dependent modulation are increasingly recognized, this review further delineates the consequences of indiscriminate NRF2 activation, demonstrating that its effects diverge across CKD etiologies and cellular contexts. These insights support a nuanced, context-specific approach to NRF2-targeted strategies and provide a framework to guide future drug development in CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NF-E2-Related Factor 2Renal Insufficiency, ChronicHumansAnimalsOxidative StressSignal TransductionDisease Progression

Stichwörter der Autor:innen

CKDNRF2dysregulationetiologytherapeutic

Substanzen

NF-E2-Related Factor 2NFE2L2 protein, human

Autor:innen und Institutionen

  • Department of Paediatrics, Yong Loo Lin School of Medicine, National University of Singapore, Singapore 117549, Singapore.
  • Khoo Teck Puat-National University Children's Medical Institute, National University Health System, Singapore 119074, Singapore.

ORCID-Profile: Tina Si Ting Lim, Yaochun Zhang

Förderung

  • National Medical Research Council, Singapore (NMRC)

Zitieren

APA

Lim, T. S. T., Ng, K. H., & Zhang, Y. (2025). NRF2 Dysregulation and Therapeutic Insights Across Chronic Kidney Diseases. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26157471

Vancouver

Lim TST, Ng KH, Zhang Y. NRF2 Dysregulation and Therapeutic Insights Across Chronic Kidney Diseases. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26157471

BibTeX
@article{Lim2025,
  author = {Lim, Tina Si Ting and Ng, Kar Hui and Zhang, Yaochun},
  title = {NRF2 Dysregulation and Therapeutic Insights Across Chronic Kidney Diseases},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26157471}
}
Kostenlos starten →